3-46438095-T-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_002343.6(LTF):āc.1943A>Gā(p.Asp648Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00019 in 1,614,040 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_002343.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTF | NM_002343.6 | c.1943A>G | p.Asp648Gly | missense_variant | 16/17 | ENST00000231751.9 | NP_002334.2 | |
LTF | NM_001321121.2 | c.1937A>G | p.Asp646Gly | missense_variant | 16/17 | NP_001308050.1 | ||
LTF | NM_001321122.2 | c.1904A>G | p.Asp635Gly | missense_variant | 19/20 | NP_001308051.1 | ||
LTF | NM_001199149.2 | c.1811A>G | p.Asp604Gly | missense_variant | 16/17 | NP_001186078.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTF | ENST00000231751.9 | c.1943A>G | p.Asp648Gly | missense_variant | 16/17 | 1 | NM_002343.6 | ENSP00000231751 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251122Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135752
GnomAD4 exome AF: 0.000194 AC: 284AN: 1461696Hom.: 4 Cov.: 31 AF XY: 0.000180 AC XY: 131AN XY: 727160
GnomAD4 genome AF: 0.000151 AC: 23AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74506
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at